Biological Science Laboratories, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan.
Biological Science Laboratories, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan.
J Mol Graph Model. 2021 Jul;106:107914. doi: 10.1016/j.jmgm.2021.107914. Epub 2021 Apr 5.
Complement component 3a receptor 1 (C3aR) is an anaphylatoxin receptor that mediates inflammatory processes. Although considerable effort has gone into discovering the antagonists and agonists of C3aR, structural insights are required to search for effective ligands and to elucidate their binding modes and the mechanism of activation and inactivation. No experimental structural data of C3aR have yet been reported. We investigated the binding mode of an antagonist of C3aR using a combination of homology modeling, ligand docking, molecular dynamics simulations, and binding free energy calculations. We produced a plausible binding model consistent with the reported experimental data. We believe that this model is appropriate for the identification of new C3aR antagonists, as it can distinguish between antagonists and decoy compounds.
补体成分 3a 受体 1(C3aR)是一种过敏毒素受体,可介导炎症过程。尽管人们已经在努力发现 C3aR 的拮抗剂和激动剂,但为了寻找有效的配体并阐明其结合模式以及激活和失活机制,还需要结构方面的见解。目前尚未报道 C3aR 的实验结构数据。我们结合同源建模、配体对接、分子动力学模拟和结合自由能计算,研究了 C3aR 拮抗剂的结合模式。我们提出了一个与报道的实验数据一致的合理结合模型。我们相信,该模型适用于鉴定新的 C3aR 拮抗剂,因为它可以区分拮抗剂和诱饵化合物。